Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malaria

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    February 2024
  1. THE LANCET
    Malaria vaccines: a test for global health.
    Lancet. 2024;403:503.
    PubMed    


  2. ADEPOJU P
    Routine malaria vaccinations begin.
    Lancet. 2024;403:423.
    PubMed    


  3. MOORTHY V, Hamel MJ, Smith PG
    Malaria vaccines for children: and now there are two.
    Lancet. 2024 Feb 1:S0140-6736(23)02743-5. doi: 10.1016/S0140-6736(23)02743.
    PubMed    


  4. DATOO MS, Dicko A, Tinto H, Ouedraogo JB, et al
    Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
    Lancet. 2024 Feb 1:S0140-6736(23)02511-4. doi: 10.1016/S0140-6736(23)02511.
    PubMed     Abstract available


    January 2024
  5. NAKWEYA G
    Cabo Verde eliminates malaria.
    Lancet. 2024;403:341.
    PubMed    


  6. KAMYA MR, Kakuru A, Dorsey G
    Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
    Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
    PubMed    


  7. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
    Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
    PubMed     Abstract available


    November 2023
  8. ASSEFA A, Parr JB
    Universal radical cure: prospects and challenges for malaria elimination.
    Lancet. 2023 Nov 15:S0140-6736(23)01950-5. doi: 10.1016/S0140-6736(23)01950.
    PubMed    


  9. THRIEMER K, Degaga TS, Christian M, Alam MS, et al
    Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Lancet. 2023 Nov 15:S0140-6736(23)01553-2. doi: 10.1016/S0140-6736(23)01553.
    PubMed     Abstract available


  10. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    PubMed     Abstract available


    October 2023
  11. ADEPOJU P
    Malaria community welcomes WHO vaccine approval.
    Lancet. 2023;402:1316.
    PubMed    


    September 2023
  12. KESSY SA, Tibenderana JR
    Zanzibar's malaria elimination efforts: progress, challenges, and lessons.
    Lancet. 2023;402:774.
    PubMed    


  13. HAWLEY WA, Laihad FJ, Ochomo E, Achee NL, et al
    What constitutes high-quality evidence for malaria vector control?
    Lancet. 2023;402:773-774.
    PubMed    


    July 2023
  14. SAMARASEKERA U
    Climate change and malaria: predictions becoming reality.
    Lancet. 2023;402:361-362.
    PubMed    


  15. DEVI S
    12 countries to get first doses of malaria vaccine.
    Lancet. 2023;402:172.
    PubMed    


    May 2023
  16. ZAROCOSTAS J
    Gavi unveils malaria vaccine plans.
    Lancet. 2023;401:1485.
    PubMed    


    April 2023
  17. KEATING C
    Artesunate versus quinine: the controlled trials watershed.
    Lancet. 2023;401:1329-1331.
    PubMed    


  18. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available


    March 2023
  19. KAKURU A, Jagannathan P
    Can we reduce malaria in pregnancy and improve birth outcomes?
    Lancet. 2023 Mar 10:S0140-6736(23)00101-0. doi: 10.1016/S0140-6736(23)00101.
    PubMed    


    January 2023
  20. ACCROMBESSI M, Cook J, Dangbenon E, Yovogan B, et al
    Efficacy of pyriproxyfen-pyrethroid long-lasting insecticidal nets (LLINs) and chlorfenapyr-pyrethroid LLINs compared with pyrethroid-only LLINs for malaria control in Benin: a cluster-randomised, superiority trial.
    Lancet. 2023 Jan 24:S0140-6736(22)02319-4. doi: 10.1016/S0140-6736(22)02319.
    PubMed     Abstract available


  21. KILLEEN GF, Sougoufara S
    Getting ahead of insecticide-resistant malaria vector mosquitoes.
    Lancet. 2023 Jan 24:S0140-6736(23)00102-2. doi: 10.1016/S0140-6736(23)00102.
    PubMed    


    November 2022
  22. SLUTSKER L, Leke RGF
    First-trimester use of ACTs for malaria treatment in pregnancy.
    Lancet. 2022 Nov 25:S0140-6736(22)02166-3. doi: 10.1016/S0140-6736(22)02166.
    PubMed    


  23. SAITO M, McGready R, Tinto H, Rouamba T, et al
    Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
    Lancet. 2022 Nov 25:S0140-6736(22)01881-5. doi: 10.1016/S0140-6736(22)01881.
    PubMed     Abstract available


    September 2022
  24. WHITE NJ, Watson JA, Uyoga S, Williams TN, et al
    Substantial misdiagnosis of severe malaria in African children.
    Lancet. 2022;400:807.
    PubMed    


    April 2022
  25. THE LANCET
    Malaria in 2022: a year of opportunity.
    Lancet. 2022;399:1573.
    PubMed    


  26. NOOR AM, Alonso PL
    The message on malaria is clear: progress has stalled.
    Lancet. 2022 Apr 21. pii: S0140-6736(22)00732.
    PubMed    


    March 2022
  27. MOSHA JF, Kulkarni MA, Lukole E, Matowo NS, et al
    Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial.
    Lancet. 2022;399:1227-1241.
    PubMed     Abstract available


    February 2022
  28. WHITE NJ, Day NPJ, Ashley EA, Smithuis FM, et al
    Have we really failed to roll back malaria?
    Lancet. 2022;399:799-800.
    PubMed    


    January 2022
  29. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    PubMed    


    December 2021
  30. VAN DER PLUIJM RW, Phyo AP, Lek D, White NJ, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
    Lancet. 2021;396:1976-1977.
    PubMed    


  31. WANG J, Xu C, Wong YK, Ma N, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution.
    Lancet. 2021;396:1976.
    PubMed    


  32. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    PubMed    


    October 2021
  33. SAMARASEKERA U
    Cautious optimism for malaria vaccine roll-out.
    Lancet. 2021;398:1394.
    PubMed    


  34. THE LANCET
    Malaria vaccine approval: a step change for global health.
    Lancet. 2021;398:1381.
    PubMed    


    May 2021
  35. MOORTHY V, Binka F
    R21/Matrix-M: a second malaria vaccine?
    Lancet. 2021 May 5. pii: S0140-6736(21)01065.
    PubMed    


  36. DATOO MS, Natama MH, Some A, Traore O, et al
    Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
    Lancet. 2021 May 5. pii: S0140-6736(21)00943.
    PubMed     Abstract available


    April 2021
  37. LANE R
    Faith Osier: inspirational immunologist.
    Lancet. 2021;397:1533.
    PubMed    


    March 2021
  38. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    PubMed    


    February 2021
  39. BATH D, Cook J, Govere J, Mathebula P, et al
    Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.
    Lancet. 2021;397:816-827.
    PubMed     Abstract available


  40. STERNBERG ED, Cook J, Alou LPA, Assi SB, et al
    Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial.
    Lancet. 2021;397:805-815.
    PubMed     Abstract available


  41. HSIANG MS, Mumbengegwi D, Chimumbwa J
    Mini-outbreak response for malaria using indoor residual spraying.
    Lancet. 2021;397:771-773.
    PubMed    


  42. CHANDA E
    Averting malaria transmission with lethal house lure intervention.
    Lancet. 2021;397:769-771.
    PubMed    


    December 2020

  43. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    Lancet. 2020;396:1829-1840.
    PubMed     Abstract available


  44. ASHLEY EA, Yeka A
    Seasonal malaria chemoprevention: closing the know-do gap.
    Lancet. 2020;396:1778-1779.
    PubMed    


    November 2020
  45. MAKONI M
    Violence leads to health emergencies in Mozambique.
    Lancet. 2020;396:1621.
    PubMed    


    April 2020
  46. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.